Tag Archives: Marketing

Data: Is Bigger Always Better?

By Guest Blogger | Published: May 15, 2013
One of the things that we’re hearing a lot about right now is big data. We’re told that we’re entering an era of big data that will come to transform business and government services alike. For data, so the thinking goes, the bigger the better. But, asks Agnitio’s Morten Hjelmsoe,  is this always the case?
Posted in Guest Blog, Marketing, Op-Ed | Also tagged , | Leave a comment

Forget Digital Differentiation: Focus on Cross-Channel 'Fusion'

By Guest Blogger | Published: April 17, 2013
Forget digital differentiation and innovation. You need to be focusing on cross-channel ‘fusion’, writes Peter Houston. Like you, I get invites to attend educational webinars on an almost daily basis; I probably actually attend one every couple of weeks. Most invites get passed over because it’s not my field, I’ve heard it all before or I don’t [...]
Posted in E-Media, Guest Blog, Technology, social media | Also tagged , , | 2 Comments

Marketing: Harnessing the Power of 'Pull'

By Guest Blogger | Published: April 3, 2013
Pull marketing – rethinking channel building A big problem Since the early days of the internet, we’ve been busy creating websites and other digital channels. It’s not an exaggeration to say that most pharmaceutical companies already have hundreds of websites and still more are coming. And now everybody is building apps. There’s a lot of activity here and in many ways [...]
Posted in Europe, Global, Guest Blog, Marketing, Strategy | Also tagged , , | Leave a comment

Changing the DNA of Pharma Patient Adherence Programs

By Guest Blogger | Published: March 12, 2013
by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors.  Pharma is also experiencing epigenetic change.  Human genes are formed from DNA, which are instructions much like a blueprint.  Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
Posted in E-Media, Marketing, Patient Communication, compliance, healthcare, patient compliance, patient education | Also tagged , , , , , | 3 Comments

US v. Caronia: What Constitutes 'Truthful' Speech?

By Ben Comer | Published: December 5, 2012
If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?
Posted in Advertising, FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy, compliance | Also tagged , , , , , , , , , , , , , , , , , | 1 Comment